Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026

Wave Life Sciences (Nasdaq: WVE) will host a live webcast and conference call at 8:30 a.m. ET on Thursday, February 26, 2026 to review fourth quarter and full year 2025 financial results and provide business updates.

Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) will host a live webcast and conference call at 8:30 a.m. ET on Thursday, February 26, 2026 to review fourth quarter and full year 2025 financial results and provide business updates.

Investors can access the event via the company’s Investor Events page; an archived webcast will be posted on the Wave Life Sciences website after the live event.

Argus Feb 19 session

+0.53% close to close Open Argus

Details

News Market Reaction – WVE

In the Feb 19 session, WVE gained 0.53%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules Wave’s Q4 and full-year 2025 earnings call for February 26, 2026 at 8:30...

Analysis

This announcement schedules Wave’s Q4 and full-year 2025 earnings call for February 26, 2026 at 8:30 a.m. ET, continuing a consistent cadence of quarterly updates seen throughout 2025. Historical earnings-related releases have produced mixed share reactions, with an average move of -1.43%. Investors may focus on upcoming disclosures about cash runway, recent capital raises, and progress across key RNA programs when the full results are released.

Key Figures

Earnings call time: 8:30 a.m. ET Earnings date: February 26, 2026

Earnings call time

8:30 a.m. ET

Scheduled Q4 and full year 2025 results call on February 26, 2026

Earnings date

February 26, 2026

Date of Q4 and full year 2025 webcast and conference call

Previous Earnings Reports

5 past events · Latest: 2025-11-10

Same Type 5 events

1. 2025-11-10

   Q3 2025 earnings

   24h Move

   -10.3%

   Reported Q3 2025 financials with detailed WVE-007 and WVE-006 data.

2. 2025-11-04

   Earnings call scheduled

   24h Move

   -3.6%

   Announced November 10, 2025 Q3 results webcast and conference call.

3. 2025-07-30

   Q2 2025 earnings

   24h Move

   -1.9%

   Released Q2 2025 results and pipeline progress for key programs.

4. 2025-07-23

   Earnings call scheduled

   24h Move

   +7.9%

   Set July 30, 2025 webcast to discuss Q2 2025 results.

5. 2025-05-08

   Q1 2025 earnings

   24h Move

   +0.8%

   Reported Q1 2025 results and multiple clinical pipeline updates.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, February 26, 2026, to review the company’s fourth quarter and full year 2025 financial results and provide business updates.

The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events.

Analysts planning to participate during the Q&A portion of the live call can join the conference call at the audio-conferencing link here.

Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA editing (AIMers), provides Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s pipeline is focused on its obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006) and PNPLA3 I148M liver disease (WVE-008) programs, and also includes clinical programs in Duchenne muscular dystrophy and Huntington’s disease, as well as several preclinical programs utilizing the company’s versatile RNA medicines platform. Driven by the calling to “Reimagine Possible,” Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X and LinkedIn.

Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827

Investors:
James Salierno
Director, Investor Relations
+1 617-949-4043
InvestorRelations@wavelifesci.com

Media:
Katie Sullivan
Senior Director, Corporate Communications
+1 617-949-2936
MediaRelations@wavelifesci.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Wave Life Sciences (WVE) present its Q4 and full year 2025 results?

Wave Life Sciences will present results at 8:30 a.m. ET on February 26, 2026. According to Wave Life Sciences, the company will host a live webcast and conference call that day to review fourth quarter and full year 2025 financial results and give business updates.

How can investors access the Wave Life Sciences (WVE) February 26, 2026 webcast?

Investors can access the webcast via the company’s Investor Events page on its website. According to Wave Life Sciences, the live webcast and conference call link is available on the investors section under "Investor Events" and will be archived after the event.

Will the Wave Life Sciences (WVE) February 26, 2026 webcast be available after the live event?

Yes. An archived version of the webcast will be available on the company website after the live event. According to Wave Life Sciences, the archived webcast will be posted on the Wave Life Sciences website following the conference call.

Can analysts ask questions during the Wave Life Sciences (WVE) February 26, 2026 call?

Yes. Analysts may participate during the Q&A portion of the live call using the conference call audio link. According to Wave Life Sciences, analysts planning to ask questions should join the conference call via the provided audio-conferencing link.

Where is the Wave Life Sciences (WVE) investor event information posted for the February 26, 2026 presentation?

Event details are posted on the Wave Life Sciences investor relations "Events" page. According to Wave Life Sciences, the investors section hosts the webcast link, call details, and the archived webcast after the presentation.